AGREEMENT OPENS UP $1.3 BILLION MARKET FOR EMEFCY

Written on the 10 October 2016

AGREEMENT OPENS UP $1.3 BILLION MARKET FOR EMEFCY

EMEFCY (ASX: EMC) has signed a deployment and distribution partnership for its Membrane Aerated Biofilm Reactor (MABR) wastewater treatment technology with Beijing Sinorichen Environmental Protection Corporation.

The agreement opens up access to a market worth up to $1.3 billion for the Melbourne-based company, which manufactures its technology out of Israel.

The Chinese government has a five-year plan to build new rural wastewater treatment plants supporting a population of around 50 million people in the provinces in Beijing and to its north.

Sinorichen has an established wastewater treatment consulting business and it intends to deploy the MABR-based wastewater treatment systems to rural communities in the Beijing Province and throughout northern China.

The partnership starts with a demonstration project in Miyun district and when that meets required performance criteria, the parties will launch a multi-phase deployment roll out plan. First, Sinorichen will use the systems for up to seventy rural installations each worth between $50,000-$250,000. It will then market the technology throughout northern China.

Richard Irving, Executive Chairman of Emefcy says Miyun District is one of China's most progressive provinces and Sinorichen represents a Emefcy's "preferred profile of partnership in China", and will accelerate deployment in other provinces.

"Emefcy is investing substantial resources and starting to make important inroads in penetrating the rural wastewater treatment market in China," he says.

The MABR modules will initially be produced at Emefcy's manufacturing facility in Israel, but the company of seeking licence approvals to establish manufacturing facilities in Jiangsu Province and the first manufacturing line in China is expected to be in place by the second quarter of 2017.

The first Sinorichen installed MABR-based system is scheduled to be commissioned during the fourth quarter of 2016 and provisional certification is expected by the third quarter for 2017.

For all joint future contracts, Sinorichen will purchase MABR modules from Emefcy, will integrate them under Emefcy's technical guidance into a complete treatment system and provide ongoing plant maintenance and related services.

This is Emefcy's second strategic partnership announcement in two months following its announcement on 15 August of a distribution agreement with Wuxi Municipal Design Institute.

Emefcy shares are trading up 11.59 per cent on the ASX this morning at $1.155 per share.

 


Latest News

WHY VIDEO IS A "GIVEN" FOR BUSINESS

IN TODAY's digital-driven world, video is king and if used right, it can push a company's brand and brand ...

BRAMBLES TUMBLES AFTER REDUCING GUIDANCE

BRAMBLES (ASX: BXB) will miss its first-half guidance due to cost pressures at its North America business.

The com...

VILLAGE ROADSHOW PARKS HURT BY DREAMWORLD TRAGEDY

QUEENSLAND visitors to Village Roadshow (ASX: VRL) theme parks have declined 12 per cent in the wake of four deaths a...

ASF UNVEILS TRAFFIC PLANS FOR THE SPIT

A SECOND bridge over the Nerang River is the centrepiece of the ASF Consortium's plan to improve traffic flow ...

Related News

CARSALES CEO RETIRES AS NEW COMPETITOR COX FINALISES MERGER

CARSALES will have a new CEO as it takes on a fresh challenger to its crown as the dominant online car sales portal i...

BUSINESS CONFIDENCE AT A SIX-YEAR HIGH

SMALL and medium businesses have entered 2017 with their confidence at a six-year high, building on strong gains m...

CONSUMERS PESSIMISTIC ENTERING 2017

CONSUMER confidence remains at its weakest point since April 2016, according to the latest Westpac Melbourne Institut...

RISE OF STARTUP SUPPORT PROGRAMS NOT AS ROSY AT IT SEEMS

ENTREPRENEURIAL cultivation companies in Australia are appearing quickly, but questions have been raised about whe...

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter